TY - JOUR T1 - Impact of <em>N</em>-Acetylcysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study JF - ERJ Open Research JO - erjor DO - 10.1183/23120541.00542-2021 SP - 00542-2021 AU - Paola Faverio AU - Paola Rebora AU - Emanuela Rossi AU - Savino del Giudice AU - Filippo Montanelli AU - Laura Garzillo AU - Sara Busnelli AU - Fabrizio Luppi AU - Maria Grazia Valsecchi AU - Alberto Pesci Y1 - 2021/01/01 UR - http://openres.ersjournals.com/content/early/2021/11/18/23120541.00542-2021.abstract N2 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may cause pneumonia and acute respiratory distress syndrome, whose pathogenesis has been partially related to an increased systemic inflammatory response with great production of pro-inflammatory cytokines causing a “cytokine storm” and an oxidative stress imbalance [1].FootnotesThis manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.Conflict of interest: Dr. Faverio has nothing to disclose.Conflict of interest: Dr. Rebora has nothing to disclose.Conflict of interest: Dr. Rossi has nothing to disclose.Conflict of interest: Dr. Del Giudice has nothing to disclose.Conflict of interest: Dr. Montanelli has nothing to disclose.Conflict of interest: Dr. Garzillo has nothing to disclose.Conflict of interest: Dr. Busnelli has nothing to disclose.Conflict of interest: Dr. Luppi has nothing to disclose.Conflict of interest: Dr. Valsecchi has nothing to disclose.Conflict of interest: Dr. Pesci has nothing to disclose. ER -